VIVS (VivoSim Labs, Inc. Common Stock) Stock Analysis - Analyst Ratings

VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of May 21, 2026, VIVS trades at $1.32 with a market cap of $3.68M and a P/E ratio of 0.00. VIVS moved +0.00% today. Year to date, VIVS is -33.33%; over the trailing twelve months it is -35.96%. Its 52-week range spans $1.25 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate VIVS?

The average price target is $0.00.

VIVS Key Metrics

Key financial metrics for VIVS
MetricValue
Price$1.32
Market Cap$3.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.30
52-Week Low$1.25
Volume170.69K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

VIVS Analyst Consensus

VIVS analyst coverage data. Average price target: $0.00.

Latest VIVS News

Recent VIVS Insider Trades

  • Gobel David bought 3.27K (~$7.30K) on Nov 17, 2025.

Common questions about VIVS

What do analysts rate VIVS?
The average price target is $0.00.
Does Rallies show VIVS price targets?
Yes. Rallies tracks VIVS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is VIVS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VIVS. It does not provide personalized investment advice.
VIVS

VIVS